|
|
Exchange: |
Nasdaq Small Cap |
Security
Type: |
Common |
Shares
Out: |
15,080,000 |
Market
Cap: |
32.12(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$1.06 - $2.77 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Cumberland Pharmaceuticals is a pharmaceutical company engaged on the acquisition, development and commercialization of prescription products. Co.'s portfolio of brands include: Acetadote® (acetylcysteine) injection, for the treatment of acetaminophen poisoning; Caldolor® (ibuprofen) injection, for the treatment of pain and fever; Kristalose® (lactulose) for the treatment of constipation; Omeclamox®-Pak, (omeprazole, clarithromycin, amoxicillin) for the treatment of Helicobacter pylori infection and related duodenal ulcer disease; and Vaprisol® (conivaptan) injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
17,526 |
28,768 |
28,768 |
28,768 |
Total Buy Value |
$24,053 |
$38,387 |
$38,387 |
$38,387 |
Total People Bought |
4 |
4 |
4 |
4 |
Total Buy Transactions |
136 |
232 |
232 |
232 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-11-03 |
2024-08-02 |
2024-02-02 |
2023-02-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Young Caroline |
Director |
|
2024-12-20 |
4 |
AB |
$2.35 |
$5 |
D/D |
2 |
29,818 |
|
-0% |
|
Krogulski Kenneth |
Director |
|
2024-12-20 |
4 |
AB |
$2.35 |
$707 |
D/D |
301 |
276,343 |
|
-0% |
|
Jones James |
Director |
|
2024-12-20 |
4 |
AB |
$2.35 |
$92 |
D/D |
39 |
40,146 |
|
-0% |
|
Kazimi A J |
Chairman and CEO |
|
2024-12-20 |
4 |
AB |
$2.35 |
$92 |
D/D |
39 |
5,702,296 |
|
-0% |
|
Young Caroline |
Director |
|
2024-12-19 |
4 |
AB |
$2.33 |
$9 |
D/D |
4 |
29,816 |
|
-3% |
|
Krogulski Kenneth |
Director |
|
2024-12-19 |
4 |
AB |
$2.33 |
$620 |
D/D |
266 |
276,042 |
|
-3% |
|
Jones James |
Director |
|
2024-12-19 |
4 |
AB |
$2.33 |
$93 |
D/D |
40 |
40,107 |
|
-3% |
|
Kazimi A J |
Chairman and CEO |
|
2024-12-19 |
4 |
AB |
$2.33 |
$93 |
D/D |
40 |
5,702,257 |
|
-3% |
|
Young Caroline |
Director |
|
2024-12-18 |
4 |
AB |
$2.19 |
$22 |
D/D |
10 |
29,812 |
|
-3% |
|
Krogulski Kenneth |
Director |
|
2024-12-18 |
4 |
AB |
$2.19 |
$683 |
D/D |
312 |
275,776 |
|
-3% |
|
Jones James |
Director |
|
2024-12-18 |
4 |
AB |
$2.19 |
$107 |
D/D |
49 |
40,067 |
|
-3% |
|
Kazimi A J |
Chairman and CEO |
|
2024-12-18 |
4 |
AB |
$2.19 |
$107 |
D/D |
49 |
5,702,217 |
|
-3% |
|
Young Caroline |
Director |
|
2024-12-17 |
4 |
AB |
$2.12 |
$21 |
D/D |
10 |
29,802 |
|
7% |
|
Krogulski Kenneth |
Director |
|
2024-12-17 |
4 |
AB |
$2.12 |
$661 |
D/D |
312 |
275,464 |
|
7% |
|
Jones James |
Director |
|
2024-12-17 |
4 |
AB |
$2.12 |
$104 |
D/D |
49 |
40,018 |
|
7% |
|
Kazimi A J |
Chairman and CEO |
|
2024-12-17 |
4 |
AB |
$2.12 |
$104 |
D/D |
49 |
5,702,168 |
|
7% |
|
Young Caroline |
Director |
|
2024-12-16 |
4 |
AB |
$2.21 |
$22 |
D/D |
10 |
29,792 |
|
7% |
|
Krogulski Kenneth |
Director |
|
2024-12-16 |
4 |
AB |
$2.21 |
$690 |
D/D |
312 |
275,152 |
|
7% |
|
Jones James |
Director |
|
2024-12-16 |
4 |
AB |
$2.21 |
$108 |
D/D |
49 |
39,969 |
|
7% |
|
Kazimi A J |
Chairman and CEO |
|
2024-12-16 |
4 |
AB |
$2.21 |
$108 |
D/D |
49 |
5,702,119 |
|
7% |
|
Young Caroline |
Director |
|
2024-12-13 |
4 |
AB |
$2.33 |
$16 |
D/D |
7 |
29,782 |
|
-5% |
|
Krogulski Kenneth |
Director |
|
2024-12-13 |
4 |
AB |
$2.33 |
$459 |
D/D |
197 |
274,840 |
|
-5% |
|
Jones James |
Director |
|
2024-12-13 |
4 |
AB |
$2.33 |
$75 |
D/D |
32 |
39,920 |
|
-5% |
|
Kazimi A J |
Chairman and CEO |
|
2024-12-13 |
4 |
AB |
$2.33 |
$75 |
D/D |
32 |
5,702,070 |
|
-5% |
|
Young Caroline |
Director |
|
2024-12-12 |
4 |
AB |
$2.19 |
$15 |
D/D |
7 |
29,775 |
|
4% |
|
2910 Records found
|
|
Page 1 of 117 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|